HomeNewsNeuroscience

  • Cadent announces FDA Clearance of IND of CAD-9303 for Schizophrenia

    • March 11, 2020
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Recent MS survey, sponsored by Celgene, highlights useful patient insights

    • October 16, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Spectramax light therapy can be a potential treatment for Parkinson’s disease

    • October 14, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Brain antioxidant levels can detect progression of Alzheimer’s Disease, study states

    • October 14, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • FDA approves Galcanezumab (Emgality) for Preventive Migraine Treatment

    • October 8, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Smartphones can be used to detect Parkinson’s symptoms early, research says

    • October 8, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Teva Announces AJOVY™ (fremanezumab) approval in the US market

    • September 17, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Further evidence generated for Neurofilament light chain as MS biomarker

    • September 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Xenon includes Phase 3 Ready molecule in pipeline for Epilepsy

    • September 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Ibudilast shows benefits on slowing brain shrinkage in the latest trial results

    • September 6, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more